Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2651-2660 of 2871 for cancer

Edit search filters
  1. Immediate And Long-Term Effects Of Improved Respiratory Function On Local Tissue Oxygen Delivery And Brain Circulation In The Brain

    Rochester, MN

  2. The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)

    Rochester, MN

  3. A Quality of Life Assessment of Patients with Biliary Obstruction Undergoing Endoscopic or Percutaneous Drainage

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study of Magnetic Resonance Elastography for Measuring Cancerous Tumor Response Following Treatment with Chemotherapy

    Rochester, MN

  5. Factors Contributing to Delay in Diagnosis of Bone/Soft Tissue Sarcoma

    Rochester, MN

  6. 68GaFAPI-46 PET/CT For Pancreatic Ductal Adenocarcinoma

    Rochester, MN

  7. Advanced MR Imaging In Sarcoma Patients

    Rochester, MN

  8. A Biobank for Pancreatic Diseases

    Rochester, MN

  9. Closing the Gap: Improving Cancer Screening in Patients with Limited English Proficiency

    Rochester, MN

  10. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T)

    Jacksonville, FL

.

Mayo Clinic Footer